Ondansetron 2 mg/mL Single-Dose Vial, 25 x 2 mL - Bx 25 (Medline)Ondansetron 2 mg mL Single Dose Vial, 25 x 2 mL Ondansetron Injection is a 5 HT3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. (1. 1) postoperative nausea and or vomiting. (1. 2)

BUD Date-  2026-08-17

BUD -2/15/2027

For IM Only

including changes in vision

non-woven sponges designed for moderate cleansing

Supplied from: Anazao

03 mg / mL

UNSPSC 51171816

0030  4094759012

*Stock Limitation*  Max purchase amount of 10 vials per order/account every two weeks

Clearly labels medications that should be discarded after 28 days

composed of five strong fiber layers for exceptionally high barrier strength